ARCHIVES

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Treatment For Late-Stage Cervical Cancer

June 30, 2006

Why Four? NCI Official Challenged To Explain Rational For Proposed Number Of Groups

March 25, 2011

In Brief: ACS to support $2 Billion NCI Budget; NCAB Backs Minority Enhancement Core Supplements

February 19, 1988

Hopkins Investigator Dies In Fall From Denver Hotel Window

May 27, 1977

Group Opposes Bill To Allow Drug Sales After Phase I.

May 26, 2006

Racker Withdraws Some Claims Made In Science Article, Says Data Are “No Question A Mess”

September 11, 1981